Is Innospec Stock a Good Investment?
Innospec Investment Advice | IOSP |
- Examine Innospec's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Innospec's leadership team and their track record. Good management can help Innospec navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Specialty Chemicals space and any emerging trends that could impact Innospec's business and its evolving consumer preferences.
- Compare Innospec's performance and market position to its competitors. Analyze how Innospec is positioned in terms of product offerings, innovation, and market share.
- Check if Innospec pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Innospec's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Innospec stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Innospec is a good investment.
Sell | Buy |
Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Innospec Stock
Researching Innospec's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 99.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 1.64. Some equities with similar Price to Book (P/B) outperform the market in the long run. Innospec last dividend was issued on the 20th of May 2025. The entity had 2:1 split on the 23rd of July 2007.
To determine if Innospec is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Innospec's research are outlined below:
| Innospec generated a negative expected return over the last 90 days | |
| Over 99.0% of the company shares are owned by institutional investors | |
| On 30th of May 2025 Innospec paid $ 0.84 per share dividend to its current shareholders | |
| Latest headline from finance.yahoo.com: Shareholders in Innospec are in the red if they invested a year ago |
Innospec Quarterly Good Will |
|
Innospec uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Innospec. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Innospec's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 13th of February 2024 Upcoming Quarterly Report | View | |
| 1st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 13th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Innospec's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Innospec's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2002-02-12 | 2001-12-31 | 0.14 | 0.16 | 0.02 | 14 | ||
2001-10-29 | 2001-09-30 | 0.12 | 0.14 | 0.02 | 16 | ||
2001-04-30 | 2001-03-31 | 0.08 | 0.06 | -0.02 | 25 | ||
2009-05-06 | 2009-03-31 | 0.23 | 0.26 | 0.03 | 13 | ||
2008-10-30 | 2008-09-30 | 0.24 | 0.21 | -0.03 | 12 | ||
2007-08-01 | 2007-06-30 | 0.24 | 0.27 | 0.03 | 12 | ||
2005-10-24 | 2005-09-30 | -0.24 | -0.21 | 0.03 | 12 | ||
1999-10-28 | 1999-09-30 | 0.4 | 0.44 | 0.04 | 10 |
Know Innospec's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Innospec is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Innospec backward and forwards among themselves. Innospec's institutional investor refers to the entity that pools money to purchase Innospec's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Hhg Plc | 2025-03-31 | 474.5 K | Nuveen Asset Management, Llc | 2024-12-31 | 471.1 K | Nuveen, Llc | 2025-03-31 | 453.5 K | Financial Harvest, Llc | 2025-03-31 | 433.8 K | Westwood Holdings Group Inc | 2025-03-31 | 382.4 K | Charles Schwab Investment Management Inc | 2025-03-31 | 354.7 K | Brown Advisory Holdings Inc | 2025-03-31 | 329.4 K | Northern Trust Corp | 2025-03-31 | 318.3 K | Jpmorgan Chase & Co | 2025-03-31 | 273 K | Blackrock Inc | 2025-03-31 | 3.7 M | Vanguard Group Inc | 2025-03-31 | 3.2 M |
Innospec's market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.07 B.Market Cap |
|
Innospec's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.03 | 0.03 | |
| Return On Capital Employed | 0.13 | 0.10 | |
| Return On Assets | 0.02 | 0.02 | |
| Return On Equity | 0.03 | 0.03 |
Determining Innospec's profitability involves analyzing its financial statements and using various financial metrics to determine if Innospec is a good buy. For example, gross profit margin measures Innospec's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Innospec's profitability and make more informed investment decisions.
Evaluate Innospec's management efficiency
As of 07/21/2025, Return On Tangible Assets is likely to drop to 0.03. In addition to that, Return On Capital Employed is likely to drop to 0.1. At this time, Innospec's Non Current Liabilities Total is relatively stable compared to the past year. As of 07/21/2025, Change To Liabilities is likely to grow to about 78.1 M, while Total Current Liabilities is likely to drop slightly above 240.4 M. Innospec's management efficiency ratios could be used to measure how well Innospec manages its routine affairs as well as how well it operates its assets and liabilities.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 48.78 | 51.22 | |
| Tangible Book Value Per Share | 30.81 | 32.35 | |
| Enterprise Value Over EBITDA | 11.13 | 5.93 | |
| Price Book Value Ratio | 2.27 | 1.33 | |
| Enterprise Value Multiple | 11.13 | 5.93 | |
| Price Fair Value | 2.27 | 1.33 | |
| Enterprise Value | 1.7 B | 1.7 B |
Leadership at Innospec emphasizes sustainable growth and financial prudence. Our analysis evaluates how these priorities impact the stock's performance in the market.
Basic technical analysis of Innospec Stock
As of the 21st of July, Innospec retains the Risk Adjusted Performance of (0.03), standard deviation of 1.45, and Market Risk Adjusted Performance of (0.07). Innospec technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.Innospec's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Innospec insiders, such as employees or executives, is commonly permitted as long as it does not rely on Innospec's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Innospec insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Innospec's Outstanding Corporate Bonds
Innospec issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Innospec uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Innospec bonds can be classified according to their maturity, which is the date when Innospec has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Understand Innospec's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Innospec's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | (0.07) | |||
| Mean Deviation | 1.08 | |||
| Coefficient Of Variation | (2,658) | |||
| Standard Deviation | 1.45 | |||
| Variance | 2.1 | |||
| Information Ratio | (0.13) | |||
| Jensen Alpha | (0.17) | |||
| Total Risk Alpha | (0.27) | |||
| Treynor Ratio | (0.08) | |||
| Maximum Drawdown | 6.32 | |||
| Value At Risk | (2.76) | |||
| Potential Upside | 2.47 | |||
| Skewness | (0.09) | |||
| Kurtosis | 0.1015 |
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | (0.07) | |||
| Mean Deviation | 1.08 | |||
| Coefficient Of Variation | (2,658) | |||
| Standard Deviation | 1.45 | |||
| Variance | 2.1 | |||
| Information Ratio | (0.13) | |||
| Jensen Alpha | (0.17) | |||
| Total Risk Alpha | (0.27) | |||
| Treynor Ratio | (0.08) | |||
| Maximum Drawdown | 6.32 | |||
| Value At Risk | (2.76) | |||
| Potential Upside | 2.47 | |||
| Skewness | (0.09) | |||
| Kurtosis | 0.1015 |
Consider Innospec's intraday indicators
Innospec intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Innospec stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Innospec Corporate Filings
| 30th of May 2025 Other Reports | ViewVerify | |
F4 | 15th of May 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 14th of May 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 13th of May 2025 Other Reports | ViewVerify |
Innospec Stock media impact
There is far too much social signal, news, headlines, and media speculation about Innospec that are available to investors today. This information is accessible both publicly - through Innospec's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Innospec-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Innospec news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Innospec relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Innospec's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Innospec alpha.
Innospec Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Innospec can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Innospec Historical Investor Sentiment
Investor biases related to Innospec's public news can be used to forecast risks associated with an investment in Innospec. The trend in average sentiment can be used to explain how an investor holding Innospec can time the market purely based on public headlines and social activities around Innospec. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Innospec's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Innospec and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Innospec news discussions. The higher the estimate score, the more favorable the investor's outlook on Innospec.
Innospec Corporate Management
| David CPA | General VP | Profile | |
| Trey Griffin | Senior Resources | Profile | |
| Graeme Blair | Head Finance | Profile | |
| Corbin Barnes | Senior Relations | Profile |
Additional Tools for Innospec Stock Analysis
When running Innospec's price analysis, check to measure Innospec's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innospec is operating at the current time. Most of Innospec's value examination focuses on studying past and present price action to predict the probability of Innospec's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innospec's price. Additionally, you may evaluate how the addition of Innospec to your portfolios can decrease your overall portfolio volatility.